- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05326581
Optimization of Sequences to Improve the Quality and Comfort of the Magnetic Resonance Imaging Examination (OPTIM)
August 31, 2022 updated by: Fondation Ophtalmologique Adolphe de Rothschild
The people included will carry out an MRI comprising the sequence currently used in routine care and the different variants of the sequence being tested, for the optimization of the parameters.
The duration of the examination (or the extension of the examination planned as part of patient care) will be from a few minutes to an hour depending on the sequences to be optimized.
Subjects who agree to research for more than 30 minutes in the MRI machine will be compensated with a multi-brand gift voucher worth 30 euros.
Study Overview
Detailed Description
The people included will carry out an MRI comprising the sequence currently used in routine care and the different variants of the sequence being tested, for the optimization of the parameters.
The duration of the examination (or the extension of the examination planned as part of patient care) will be from a few minutes to an hour depending on the sequences to be optimized.
Subjects who agree to research for more than 30 minutes in the MRI machine will be compensated with a multi-brand gift voucher worth 30 euros
Study Type
Observational
Enrollment (Anticipated)
750
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Amélie Yavchitz, MD
- Phone Number: +33 (0)148036454
- Email: ayavachitz@for.paris
Study Contact Backup
- Name: Julien Savatovsky, MD
- Email: jsavatovsky@for.paris
Study Locations
-
-
-
Paris, France, 75019
- Recruiting
- Hôpital Fondation Adolphe de Rothschild
-
Contact:
- Julien Savatovsky, MD
- Email: jsavatovsky@for.paris
-
Principal Investigator:
- Julien Savatovsky, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Participation in the study will be offered to patients performing MRI imaging as part of the treatment as well as to healthy volunteers among the staff.
Description
Inclusion Criteria:
- Subject over 18 years old
- Consent to participate in the study
- Member of or beneficiary of a social security scheme
- For patients: benefiting from an MRI examination as part of their care
- For volunteers: Consent to be informed if an unexpected anomaly is revealed by the imaging.
Exclusion Criteria:
- Subject benefiting from a measure of legal protection
- Pregnant or breastfeeding women
- For volunteers: Contraindication to MRI (detailed contraindications questionnaire, THI score >28 questionnaire, hearing sensitivity questionnaire grade >1)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
PATIENTS
patients benefiting from an MRI examination as part of their care
|
The people included will carry out an MRI comprising the sequence currently used in routine care and the different variants of the sequence being tested, for the optimization of the parameters.
The duration of the examination (or the extension of the examination planned as part of patient care) will be from a few minutes to an hour depending on the sequences to be optimized.
Subjects who agree to research for more than 30 minutes in the MRI machine will be compensated with a multi-brand gift voucher worth 30 euros.
|
VOLUNTEERS
healthy volunteers among staff.
|
The people included will carry out an MRI comprising the sequence currently used in routine care and the different variants of the sequence being tested, for the optimization of the parameters.
The duration of the examination (or the extension of the examination planned as part of patient care) will be from a few minutes to an hour depending on the sequences to be optimized.
Subjects who agree to research for more than 30 minutes in the MRI machine will be compensated with a multi-brand gift voucher worth 30 euros.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of imagery
Time Frame: Baseline
|
Quality of imagery evaluated on a likert-type scale (range from : "very bad quality" to "very good quality") by two experts
|
Baseline
|
Presence or absence of radiological image artifact
Time Frame: Baseline
|
Presence/absence of radiological image artifact evaluated on a likert-type scale (range from : "major - impossible interpretation" to "none") by two experts
|
Baseline
|
Confidence in diagnosis
Time Frame: Baseline
|
Confidence in diagnosis evaluated on a likert-type scale (range from : "not confident" to "very confident") by two experts
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Julien Savatovksy, MD, Fondation A. de Rothschild
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 23, 2022
Primary Completion (Anticipated)
May 1, 2027
Study Completion (Anticipated)
May 1, 2027
Study Registration Dates
First Submitted
March 18, 2022
First Submitted That Met QC Criteria
April 6, 2022
First Posted (Actual)
April 13, 2022
Study Record Updates
Last Update Posted (Actual)
September 1, 2022
Last Update Submitted That Met QC Criteria
August 31, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- JSY_2021_30
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Optimized MRI Sequences
-
Fondation Ophtalmologique Adolphe de RothschildCompletedEstimate, With the Contribution of Optimized MRI, the Prevalence of Neurological and Neurovascular Manifestations on Imaging in the Event of SARS-CoV-2France
-
University Hospital, BordeauxL'Institut de RYthmologie et modélisation Cardiaque (IHU LIRYC)RecruitingMagnetic Resonance Imaging SequencesFrance
-
Brigham and Women's HospitalUnknownThe Focus of This Study Are New Pulse Sequences.United States
-
Hvidovre University HospitalCompleted
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingStandard/As Usual CBT+/EBP Initiative Implementation | Optimized Supervisor-led Implementation CoachingUnited States
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
PfizerCompletedMRI SedationUnited States, Japan
-
University of UtahWithdrawnMRI ScansUnited States
Clinical Trials on mri
-
Cambridge University Hospitals NHS Foundation TrustRecruitingBreast CancerUnited Kingdom
-
Seoul National University Bundang HospitalBayerCompletedTraumaKorea, Republic of
-
Assistance Publique Hopitaux De MarseilleActive, not recruitingMultiple SclerosisFrance
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedOsteosarcoma | Ewing Sarcoma | Paget's DiseaseUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedAdult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
University of EdinburghActive, not recruiting
-
Assistance Publique - Hôpitaux de ParisUnknownBrain Injury, Coma | Cardiac Arrest (CA) | Traumatic Brain Injury (TBI) | Aneurysmal Subarachnoid Hemorrhages (aSAH)France
-
Sheba Medical CenterUnknown
-
Abbott Medical DevicesCompletedAdverse Effect of MRI on an Implanted Pacemaker Lead | Adverse Effect of MRI on an Implanted PacemakerUnited States, Netherlands, Australia, Belgium, Finland
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupUnknownBreast Cancer | BIRADS 3 | BIRADS 4 | BIRADS 5United States